CN116217708B - 一种纯化人血浆IgM的方法 - Google Patents
一种纯化人血浆IgM的方法 Download PDFInfo
- Publication number
- CN116217708B CN116217708B CN202310042896.9A CN202310042896A CN116217708B CN 116217708 B CN116217708 B CN 116217708B CN 202310042896 A CN202310042896 A CN 202310042896A CN 116217708 B CN116217708 B CN 116217708B
- Authority
- CN
- China
- Prior art keywords
- igm
- chromatography
- purifying
- dissolving
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 16
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000004587 chromatography analysis Methods 0.000 claims abstract description 18
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims abstract description 10
- 108010035369 Cohn fraction I Proteins 0.000 claims abstract description 6
- 239000000706 filtrate Substances 0.000 claims abstract description 6
- 238000001914 filtration Methods 0.000 claims abstract description 6
- 230000001105 regulatory effect Effects 0.000 claims abstract description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- 238000003916 acid precipitation Methods 0.000 claims abstract description 4
- 238000005571 anion exchange chromatography Methods 0.000 claims abstract description 4
- 108010032597 Cohn fraction II Proteins 0.000 claims abstract description 3
- 239000002131 composite material Substances 0.000 claims abstract description 3
- 239000012535 impurity Substances 0.000 claims abstract description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 claims abstract description 3
- 230000001376 precipitating effect Effects 0.000 claims abstract description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 28
- 239000000872 buffer Substances 0.000 claims description 19
- 238000011068 loading method Methods 0.000 claims description 14
- 239000011780 sodium chloride Substances 0.000 claims description 14
- 238000012856 packing Methods 0.000 claims description 11
- 239000013622 capto Q Substances 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 3
- 238000004090 dissolution Methods 0.000 claims description 2
- 238000011067 equilibration Methods 0.000 claims 2
- 239000000047 product Substances 0.000 abstract description 11
- 108060003951 Immunoglobulin Proteins 0.000 abstract description 7
- 102000018358 immunoglobulin Human genes 0.000 abstract description 7
- 239000010836 blood and blood product Substances 0.000 abstract description 2
- 229940125691 blood product Drugs 0.000 abstract description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000007853 buffer solution Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 4
- 102000009027 Albumins Human genes 0.000 description 3
- 108010088751 Albumins Proteins 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000008215 water for injection Substances 0.000 description 3
- 238000011010 flushing procedure Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/165—Extraction; Separation; Purification by chromatography mixed-mode chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310042896.9A CN116217708B (zh) | 2023-01-28 | 2023-01-28 | 一种纯化人血浆IgM的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310042896.9A CN116217708B (zh) | 2023-01-28 | 2023-01-28 | 一种纯化人血浆IgM的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116217708A CN116217708A (zh) | 2023-06-06 |
CN116217708B true CN116217708B (zh) | 2024-04-09 |
Family
ID=86568941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310042896.9A Active CN116217708B (zh) | 2023-01-28 | 2023-01-28 | 一种纯化人血浆IgM的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116217708B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105126100A (zh) * | 2015-09-23 | 2015-12-09 | 成都蓉生药业有限责任公司 | 一种富含IgM的人免疫球蛋白制剂及其制备方法 |
CN105198993A (zh) * | 2015-09-23 | 2015-12-30 | 成都蓉生药业有限责任公司 | 一种人免疫球蛋白的IgM组分及其制备方法 |
CN111944043A (zh) * | 2020-09-01 | 2020-11-17 | 华兰生物工程重庆有限公司 | 一种从血浆废弃物中提取IgM的方法 |
CN111961130A (zh) * | 2020-08-31 | 2020-11-20 | 华兰生物工程重庆有限公司 | 一种从血浆中提取并分离IgM和IgG的方法 |
CN112409477A (zh) * | 2019-08-21 | 2021-02-26 | 广东菲鹏生物有限公司 | IgM纯化方法 |
-
2023
- 2023-01-28 CN CN202310042896.9A patent/CN116217708B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105126100A (zh) * | 2015-09-23 | 2015-12-09 | 成都蓉生药业有限责任公司 | 一种富含IgM的人免疫球蛋白制剂及其制备方法 |
CN105198993A (zh) * | 2015-09-23 | 2015-12-30 | 成都蓉生药业有限责任公司 | 一种人免疫球蛋白的IgM组分及其制备方法 |
CN112409477A (zh) * | 2019-08-21 | 2021-02-26 | 广东菲鹏生物有限公司 | IgM纯化方法 |
CN111961130A (zh) * | 2020-08-31 | 2020-11-20 | 华兰生物工程重庆有限公司 | 一种从血浆中提取并分离IgM和IgG的方法 |
CN111944043A (zh) * | 2020-09-01 | 2020-11-17 | 华兰生物工程重庆有限公司 | 一种从血浆废弃物中提取IgM的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN116217708A (zh) | 2023-06-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2729482B1 (en) | Method for purifying fc-fusion protein | |
US5169936A (en) | Protein purification on immobilized metal affinity resins effected by elution using a weak ligand | |
JP2013519652A (ja) | 単一ユニット抗体精製 | |
US20130178608A1 (en) | Protein purification by ion exchange | |
US20200283472A1 (en) | A process for purification of fc-fusion proteins | |
JP2013540787A (ja) | 単一ユニットイオン交換クロマトグラフィー抗体精製 | |
CN107964044B (zh) | 从乳样中纯化抗cd20单克隆抗体的方法 | |
CN102127165A (zh) | 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺 | |
CN104001172B (zh) | 一种静脉注射用乙型肝炎人免疫球蛋白的制备工艺 | |
CN116217708B (zh) | 一种纯化人血浆IgM的方法 | |
JPH05279396A (ja) | 第viii因子の精製法と、それによって得られた調製品 | |
US7041798B1 (en) | Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use | |
EP1802654A1 (en) | Method for the isolation of haptoglobin | |
CN115925890A (zh) | 一种抗新冠病毒中和抗体纯化方法 | |
CN110330565B (zh) | 从血浆分离组分ⅰ和ⅲ中提取静注人免疫球蛋白的方法 | |
CN102924586A (zh) | 一种利用单克隆抗体技术生产孕马血清促性腺激素的方法 | |
WO2023031965A1 (en) | Method to obtain a purified antibody composition | |
CN104004091B (zh) | 一种人免疫球蛋白的制备工艺 | |
CA3203540A1 (en) | Systems and methods for process scale isolation of immunoglobulin g | |
CN110563832A (zh) | 一种高纯度重组促卵泡刺激素纯化方法 | |
EP2721052A1 (en) | Single unit chromatography antibody purification | |
WO2011015919A1 (en) | A highly efficient process of purification and production of recombinant infliximab | |
EP4376878A1 (en) | Method to control high molecular weight aggregates in an antibody composition | |
WO2022234412A1 (en) | A process for purification of fc-fusion proteins | |
WO2023187826A1 (en) | Method to purify an antibody composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20240318 Address after: No.26, Huacai Road, Chenghua District, Chengdu, Sichuan 610000 Applicant after: CHINESE ACADEMY OF MEDICAL SCIENCE PEKING UNION MEDICAL College INSTITUTE OF BLOOD TRANSFUSION CHENGDU CHINA Country or region after: China Applicant after: ZHEJIANG HAIKANG BIOLOGICAL PRODUCTS CO.,LTD. Address before: No.26, Huacai Road, Chenghua District, Chengdu, Sichuan 610000 Applicant before: CHINESE ACADEMY OF MEDICAL SCIENCE PEKING UNION MEDICAL College INSTITUTE OF BLOOD TRANSFUSION CHENGDU CHINA Country or region before: China |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |